Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Mito-Frail Trial
NCT06027554Phase 2Recruiting
- Sponsor
- UConn Health
- Start
- Oct 2024
- Primary completion
- Mar 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of mitoquinone in frailty syndrome, Mild Cognitive Impairment (MCI), sponsored by UConn Health. Started Oct 2024; status: recruiting.
02
Drugs
mitoquinone
03
Conditions
frailty syndromeMild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT06027554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06027554.